Benjamin Halladay

Companies

• Esperion TherapeuticsChief financial officer Nov 16, 2022 to now¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• ETEsperion Therapeutics ESPR0 shares²Jul 13, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Jul 13, 2026Returned to company 705,410 shares of Esperion Therapeutics²
• Jun 17, 2026Sold 10,773 shares at $3.16 of Esperion Therapeutics³
• Mar 17, 2026Sold 6,424 shares at $2.71 of Esperion Therapeutics⁴
• Mar 13, 2026Granted 247,430 shares of Esperion Therapeutics⁵
• Dec 17, 2025Sold 7,337 shares at $3.67 of Esperion Therapeutics⁶
• Sep 17, 2025Sold 7,046 shares at $2.81 of Esperion Therapeutics⁷
• Jul 17, 2025Sold 11 shares at $1.12 of Esperion Therapeutics⁸
• Jun 17, 2025Sold 7,229 shares at $1.15 of Esperion Therapeutics⁹
• Apr 17, 2025Sold 8 shares at $0.96 of Esperion Therapeutics¹⁰
• Mar 18, 2025Sold 3,535 shares at $1.48 of Esperion Therapeutics¹¹
• Mar 14, 2025Granted 238,000 shares of Esperion Therapeutics¹²
• Feb 19, 2025Sold 11 shares at $1.86 of Esperion Therapeutics¹³
• Jan 17, 2025Sold 9 shares at $2.27 of Esperion Therapeutics¹⁴
• Dec 17, 2024Sold 3,245 shares at $2.42 of Esperion Therapeutics¹⁵
• Mar 14, 2024Granted 170,000 shares of Esperion Therapeutics¹⁶
• Mar 14, 2023Granted 9,200 shares of Esperion Therapeutics¹⁷
• Dec 9, 2022Granted 44,000 shares of Esperion Therapeutics¹⁸